Roche · 17 hours ago
2026 Summer Intern - Research Oncology
Roche is a leading biotechnology company, and they are seeking a highly motivated Summer Intern in Immuno-Oncology to join their research team. This internship offers hands-on experience in cutting-edge translational research aimed at harnessing and redirecting the immune system to treat cancer, while collaborating closely with experienced scientists.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Collaborate work with a team of scientists to design, execute and interpret experiments
Compile and present work to the greater scientific community at Genentech
Potential to participate in business critical research
Qualification
Required
Must have attained a Bachelor's Degree
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Required Majors: Biology, Cancer Immunology, Immunology, Oncology or related fields
Experience with flow cytometry, tissue processing and cell culture
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Experience with viral work
Technical expertise with genome engineering (CRISPR/Cas9) and molecular biology techniques (DNA, RNA, PCR, Western Blotting) is desirable
Some knowledge of R is preferred
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-02-05
2026-02-03
Company data provided by crunchbase